Approval · Notice of Compliance 3365 · 2003
EVRA: Notice of Compliance 3365
Issued November 19, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3365
- Date
- November 19, 2003
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site for the drug product
- Therapeutic class
- Hormonal contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRA | 02248297 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.6 MG per UNIT
- NORELGESTROMIN 6 MG per UNIT